Delivery Order SPE2DB20D7066-SPE2DB25FC3XY
Award Date 7/2/25
Potential Completion Date 7/24/25
Potential Value $6.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,863.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200 mg vials of Andexxa, an antidote used to reverse the effects of certain anticoagulant medications. The award, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $17,344.30 to AmerisourceBergen Drug Corp for the supply of Andexxa 200 mg vials. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 4, 2025, with performance occurring at the vendor's Conshohocken, Pennsylvania location. The contract utilizes no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for federal medical procurement requirements. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,672.15 to AmerisourceBergen Drug Corp for Andexxa 200 mg vials, with a completion date of July 1, 2025. This competitive, non-set-aside award reflects firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $6,931.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Andexxa 200 mg vials, with an ultimate completion date of October 9, 2025. This non-set-aside contract represents a specific pharmaceutical procurement under the company's broader federal medical supply framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Andexxa 200 mg vials, a critical reversal agent used in military and federal healthcare settings. The contract is valued at $6,931.53 with a firm fixed price structure and completion deadline of October 1, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Andexxa 200 mg vials, with a ceiling value of $17,344.30 and a firm fixed price structure. The delivery order is not set-aside and is scheduled for completion by May 15, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a competitively awarded transaction under the company's existing Indefinite Delivery Contract with...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Andexxa 200 mg vials, a critical reversal agent used in emergency medical settings. This firm fixed-price delivery order, valued at $8,672.15, represents a competitive award with no set-aside designation and is scheduled for completion by May 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office operations in Conshohocken,...
- The U.S. government has awarded a delivery order contract worth $15,050.28 to Amerisourcebergen Drug Corp's Corporate Office Division to provide the pharmaceutical product ANDEXXA 200 MG VIALS. This contract has no set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation. The contract, valued at $7,570.17, is for the supply of ANDEXXA 200 MG VIALS, a specialty pharmaceutical product. This delivery order is issued under an indefinite delivery contract (IDC) with a total potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- The Defense Logistics Agency (DLA) has awarded a $6,658.73 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the delivery of ANDEXXA 200 MG VIALS and has an ultimate completion date of May 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00...